Clinical Trial Update: Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vascular and metabolic effects of hormone therapy combined with L-Arginine in postmenopausal women; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hypercholesterolemia, Postmenopause | Phase 2 | Status: COMPLETED